hCG Improves Luteal Function and Promotes Progesterone Output through the Activation of JNK Pathway in the Luteal Granulosa Cells of the Stimulated IVF Cycles†.


Journal

Biology of reproduction
ISSN: 1529-7268
Titre abrégé: Biol Reprod
Pays: United States
ID NLM: 0207224

Informations de publication

Date de publication:
26 05 2020
Historique:
received: 22 01 2020
revised: 01 03 2020
accepted: 11 03 2020
pubmed: 13 3 2020
medline: 28 9 2021
entrez: 13 3 2020
Statut: ppublish

Résumé

Human chorionic gonadotropin (hCG) is a luteotropic hormone that promotes the survival and steroidogenic activity of corpus luteum (CL) by acting through luteinizing hormone receptors (LHRs) expressed on luteinized theca and granulosa cells (GCs). Therefore, it is used to support luteal phase in in vitro fertilization (IVF) cycles to improve clinical pregnancy rates and prevent miscarriage. However, the molecular mechanism underlying this action of hCG is not well characterized. To address this question, we designed an in vitro translational research study on the luteal GCs obtained from 58 IVF patients. hCG treatment at different concentrations and time points activated c-Jun N-terminal kinase (JNK) pathway and significantly increased its endogenous kinase activity along with upregulated expression of steroidogenic enzymes (steroidogenic acute regulatory protein (stAR), 3β-Hydroxysteroid dehydrogenase (3β-HSD)) in a dose-dependent manner in the luteal GCs. As a result, in vitro P production of the cells was significantly enhanced after hCG. When JNK pathway was inhibited pharmacologically or knocked-down with small interfering RNA luteal function was compromised, P4 production was declined along with the expression of stAR and 3β-HSD in the cells. Further, hCG treatment after JNK inhibition failed to correct the luteal defect and promote P4 output. Similar to hCG, luteinizing hormone (LH) treatment improved luteal function as well and this action of LH was associated with JNK activation in the luteal GCs. These findings could be important from the perspective of CL biology and luteal phase in human because we for the first time identify a critical role for JNK signaling pathway downstream LHR activation by hCG/LH in luteal GCs. JNK signaling pathway plays a central role in the upregulated expression of the steroidogenic enzymes StAR and 3b-HSD and augmented progesterone production by hCG/LH in human luteal granulosa cells.

Identifiants

pubmed: 32163131
pii: 5803445
doi: 10.1093/biolre/ioaa034
doi:

Substances chimiques

Chorionic Gonadotropin 0
Progesterone 4G7DS2Q64Y
Luteinizing Hormone 9002-67-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1270-1280

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Gamze Bildik (G)

Graduate School of Health Sciences, Koc University, Istanbul, Turkey.

Nazli Akin (N)

Graduate School of Health Sciences, Koc University, Istanbul, Turkey.

Yashar Esmaeilian (Y)

Graduate School of Health Sciences, Koc University, Istanbul, Turkey.

Francesko Hela (F)

Graduate School of Health Sciences, Koc University, Istanbul, Turkey.

Kayhan Yakin (K)

Graduate School of Health Sciences, Koc University, Istanbul, Turkey.
Department of Obstetrics and Gynecology, Koc University School of Medicine, Istanbul, Turkey.

Tamer Onder (T)

Department of Molecular Biology and Genetics, School of Medicine, Koc University, Istanbul, Turkey.

Bulent Urman (B)

Department of Obstetrics and Gynecology, Koc University School of Medicine, Istanbul, Turkey.

Ozgur Oktem (O)

Graduate School of Health Sciences, Koc University, Istanbul, Turkey.
Department of Obstetrics and Gynecology, Koc University School of Medicine, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH